From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...

Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product, a treatment that works by stopping HIV from getting ...

Gilead Sciences, Inc. GILD recently announced additional efficacy, safety and demographic data from its late-stage study on lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

"Madagascar’s HIV epidemic is being fueled by gaps in prevention and glaring inequalities, which urgently need to be ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Two posters compared health care resource utilization (HCRU) and financial burdens of people living with HIV with a non-HIV ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

The 2024 Sex Lives Report by LetsStopAIDS found 34% of youth diagnosed with an STI or HIV did not receive treatment — an ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...